FDA Orange Book · active-ingredient family
Olodaterol hydrochloride
Olodaterol hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:STRIVERDI RESPIMAT · NDA 203108
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · spray, metered
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| STRIVERDI RESPIMATRLD | BOEHRINGER INGELHEIM | NDA 203108 | — | Jul 31, 2014 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7727984 | Jan 19, 2027 | in 7 mo | Substance |
Olodaterol hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
